Not applicableUnknownNCT02600442
What this trial is testing
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers
Who this might be right for
Breast NeoplasmsBreast Cancer
Assistance Publique - Hôpitaux de Paris 168